Rathbones Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Sell |
446,144
-1,381
| -0.3% | -$36.8K | 0.05% | 148 |
|
|
2025
Q4 | $11.1M | Sell |
447,525
-27,010
| -6% | -$681K | 0.04% | 153 |
|
|
2025
Q3 | $12.1M | Sell |
474,535
-12,993
| -3% | -$321K | 0.05% | 151 |
|
|
2025
Q2 | $11.8M | Sell |
487,528
-72,987
| -13% | -$1.7M | 0.05% | 150 |
|
|
2025
Q1 | $14.2M | Sell |
560,515
-24,542
| -4% | -$642K | 0.07% | 142 |
|
|
2024
Q4 | $15.5M | Sell |
585,057
-20,034
| -3% | -$543K | 0.08% | 136 |
|
|
2024
Q3 | $17.5M | Buy |
605,091
+9,233
| +2% | +$269K | 0.09% | 129 |
|
|
2024
Q2 | $16.7M | Sell |
595,858
-1,402
| -0.2% | -$38.6K | 0.09% | 123 |
|
|
2024
Q1 | $16.6M | Sell |
597,260
-6,962
| -1% | -$193K | 0.1% | 125 |
|
|
2023
Q4 | $17.4M | Sell |
604,222
-31,326
| -5% | -$947K | 0.11% | 119 |
|
|
2023
Q3 | $21.1M | Buy |
635,548
+143,299
| +29% | +$5.07M | 0.15% | 114 |
|
|
2023
Q2 | $18.1M | Sell |
492,249
-6,107
| -1% | -$238K | 0.17% | 107 |
|
|
2023
Q1 | $20.3M | Sell |
498,356
-15,692
| -3% | -$678K | 0.21% | 99 |
|
|
2022
Q4 | $26.3M | Buy |
514,048
+13,280
| +3% | +$637K | 0.3% | 84 |
|
|
2022
Q3 | $21.9M | Sell |
500,768
-33,852
| -6% | -$1.64M | 0.27% | 88 |
|
|
2022
Q2 | $28M | Buy |
534,620
+11,456
| +2% | +$584K | 0.32% | 80 |
|
|
2022
Q1 | $27.1M | Sell |
523,164
-6,690
| -1% | -$347K | 0.28% | 89 |
|
|
2021
Q4 | $31.3M | Sell |
529,854
-900
| -0.2% | -$44.6K | 0.3% | 84 |
|
|
2021
Q3 | $22.8M | Sell |
530,754
-66,622
| -11% | -$2.95M | 0.25% | 92 |
|
|
2021
Q2 | $23.4M | Sell |
597,376
-22,532
| -4% | -$876K | 0.26% | 91 |
|
|
2021
Q1 | $22.5M | Sell |
619,908
-56,289
| -8% | -$2M | 0.29% | 83 |
|
|
2020
Q4 | $24.9M | Sell |
676,197
-35,031
| -5% | -$1.28M | 0.35% | 69 |
|
|
2020
Q3 | $24.8M | Buy |
711,228
+66,319
| +10% | +$2.33M | 0.42% | 61 |
|
|
2020
Q2 | $20M | Sell |
644,909
-17,009
| -3% | -$578K | 0.41% | 60 |
|
|
2020
Q1 | $20.5M | Buy |
661,918
+22,016
| +3% | +$750K | 0.6% | 49 |
|
|
2019
Q4 | $23.8M | Buy |
639,902
+13,570
| +2% | +$483K | 0.63% | 50 |
|
|
2019
Q3 | $21.4M | Buy |
626,332
+88,627
| +16% | +$3.22M | 0.61% | 55 |
|
|
2019
Q2 | $22.1M | Buy |
537,705
+2,990
| +0.6% | +$119K | 0.69% | 50 |
|
|
2019
Q1 | $21.5M | Buy |
534,715
+26,524
| +5% | +$1.06M | 0.71% | 51 |
|
|
2018
Q4 | $21M | Buy |
508,191
+61,112
| +14% | +$2.54M | 0.81% | 47 |
|
|
2018
Q3 | $18.7M | Buy |
447,079
+178,238
| +66% | +$6.86M | 0.64% | 49 |
|
|
2018
Q2 | $9.25M | Sell |
268,841
-15,192
| -5% | -$519K | 0.35% | 69 |
|
|
2018
Q1 | $9.56M | Sell |
284,033
-806,355
| -74% | -$27.7M | 0.39% | 67 |
|
|
2017
Q4 | $37.5M | Buy |
1,090,388
+3,367
| +0.3% | +$115K | 1.53% | 18 |
|
|
2017
Q3 | $36.8M | Buy |
1,087,021
+104,631
| +11% | +$3.36M | 1.6% | 16 |
|
|
2017
Q2 | $31.3M | Buy |
982,390
+44,198
| +5% | +$1.39M | 1.4% | 23 |
|
|
2017
Q1 | $30.5M | Sell |
938,192
-2,069
| -0.2% | -$65.2K | 1.39% | 16 |
|
|
2016
Q4 | $29M | Sell |
940,261
-32,909
| -3% | -$1M | 1.45% | 11 |
|
|
2016
Q3 | $31.3M | Sell |
973,170
-58,836
| -6% | -$1.97M | 1.62% | 11 |
|
|
2016
Q2 | $34.5M | Buy |
1,032,006
+90,859
| +10% | +$2.9M | 1.9% | 10 |
|
|
2016
Q1 | $26.5M | Buy |
941,147
+602,189
| +178% | +$17.2M | 1.61% | 13 |
|
|
2015
Q4 | $10M | Sell |
338,958
-11,939
| -3% | -$376K | 0.64% | 50 |
|
|
2015
Q3 | $10.5M | Sell |
350,897
-10,167
| -3% | -$326K | 0.7% | 51 |
|
|
2015
Q2 | $11.5M | Buy |
361,064
+790
| +0.2% | +$25.7K | 0.75% | 48 |
|
|
2015
Q1 | $11.9M | Buy |
360,274
+14,282
| +4% | +$454K | 0.79% | 45 |
|
|
2014
Q4 | $10.2M | Buy |
345,992
+30,515
| +10% | +$875K | 0.67% | 55 |
|
|
2014
Q3 | $8.85M | Buy |
315,477
+17,655
| +6% | +$496K | 0.61% | 60 |
|
|
2014
Q2 | $8.39M | Buy |
297,822
+6,073
| +2% | +$173K | 0.59% | 60 |
|
|
2014
Q1 | $8.89M | Buy |
291,749
+7,277
| +3% | +$217K | 0.71% | 52 |
|
|
2013
Q4 | $8.27M | Sell |
284,472
-14,332
| -5% | -$417K | 0.82% | 52 |
|
|
2013
Q3 | $8.14M | Buy |
298,804
+66,592
| +29% | +$1.81M | 0.95% | 40 |
|
|
2013
Q2 | $6.17M | Buy |
+232,212
| New | +$6.42M | 0.83% | 46 |
|
Other funds holding PFE
VCM
VPM
Rathbones Group's PFE Position: Q1 2026 in Review
Rathbones Group reduced its Pfizer (PFE) stake by 0.31% in Q1 2026, selling an estimated $36.8K and leaving 446,144 shares worth $12.5M. The position accounts for 0.05% of the portfolio, ranked #148.
Rathbones Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $37.5M in Q4 2017. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Rathbones Group held 446,144 shares of Pfizer worth $12.5M as of Q1 2026.
- Rathbones Group sold 1,381 Pfizer shares in Q1 2026, an estimated $36.8K.
- Pfizer made up 0.05% of Rathbones Group's portfolio in Q1 2026, its #148 holding.
- Rathbones Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Rathbones Group's Pfizer position peaked at $37.5M in Q4 2017.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Rathbones Group's 13F filing for Q1 2026, filed 12 May 2026.